Show Notes
1. Podcast Description:
Join oncology pharmacist Eoin Tabb as he dives into the world of infusion-related reactions (IRRs). This podcast is a must-listen for all healthcare professionals involved in cancer care. Learn how to identify, grade, and manage IRRs to ensure the safety and comfort of your patients. From mild rashes to severe emergencies, we'll cover it all, providing practical tips and real-life scenarios to enhance your knowledge and confidence.
2. Podcast Show Notes:
What are infusion-related reactions (IRRs)?
Why are IRRs different from typical side effects?
How are IRRs graded using the CTCAE scale?
What are the most common premedications used to prevent IRRs?
How to manage mild and severe IRRs, including the role of an "IRR kit"
Real-life scenarios illustrating the importance of prompt and appropriate intervention
The impact of IRRs on the patient experience and how healthcare professionals can minimise negative effects
References:
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for specific cancer types and treatments (available to members at nccn.org)
European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the management of infusion reactions to systemic anticancer therapy: https://www.esmo.org/guidelines/guidelines-by-topic/esmo-clinical-practice-guidelines-supportive-and-palliative-care/infusion-reactions-to-systemic-anticancer-therapy
https://docs.google.com/document/d/1JtUGEhbW-9D5yjSpyDbQZyZJ38-sdz0vX2l1yeVthIo/edit?usp=sharing
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: